Judson Englert
Director Técnico/Científico/I+D en CYTEIR THERAPEUTICS, INC. .
Perfil
Judson Englert is currently working as the Senior VP-Clinical Research & Development at Cyteir Therapeutics, Inc. Previously, he worked as the Director-Oncology Clinical Development at Medimmune, Inc. He holds a doctorate degree from the University of Pittsburgh.
Cargos activos de Judson Englert
| Empresas | Cargo | Inicio |
|---|---|---|
| CYTEIR THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 01/06/2020 |
Antiguos cargos conocidos de Judson Englert.
| Empresas | Cargo | Fin |
|---|---|---|
| Medimmune, Inc. | Director Técnico/Científico/I+D | - |
Formación de Judson Englert.
| University of Pittsburgh | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Cyteir Therapeutics, Inc.
 Cyteir Therapeutics, Inc. BiotechnologyHealth Technology Cyteir Therapeutics, Inc.is a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851, a novel, oral, once-daily, small molecule drug candidate that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for combination therapy in solid tumors and hematologic malignancies. The company was founded by Kevin Mills and Timothy Romberger in June 2012 and is headquartered in Lexington, MA. | Health Technology |
| Medimmune, Inc. | Health Technology |
- Bolsa de valores
- Insiders
- Judson Englert
